Using organoids to explore prenatal cocaine exposure

Keith Murphy is a Professor of Neuropharmacology at the University College Dublin (Ireland). His research lab, called The Neurotherapeutics Research Group, focuses on understanding brain dysfunction at a molecular level, identifying novel drug targets for treatment of neuropsychiatric illnesses including schizophrenia, depression, anxiety and drug addiction, and trying to develop drugs to target those different disorders. In this interview from the meeting of the Society for Neuroscience (SfN), Neuroscience 2024 (5–9 October; Chicago, IL, USA), Keith discusses his recent project that used organoids to explore the effect of cocaine on in utero developing brains, and the potential to develop drugs...